Edward L. Conn

876 total citations
12 papers, 270 citations indexed

About

Edward L. Conn is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Edward L. Conn has authored 12 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Edward L. Conn's work include Cannabis and Cannabinoid Research (3 papers), Aldose Reductase and Taurine (2 papers) and Asymmetric Synthesis and Catalysis (2 papers). Edward L. Conn is often cited by papers focused on Cannabis and Cannabinoid Research (3 papers), Aldose Reductase and Taurine (2 papers) and Asymmetric Synthesis and Catalysis (2 papers). Edward L. Conn collaborates with scholars based in United States and China. Edward L. Conn's co-authors include Allyn T. Londregan, Kevin D. Hesp, Banavara L. Mylari, Peter J. Oates, Melissa O’Gorman, James B. Coutcher, William J. Zembrowski, David A. Beebe, Michael C. Linhares and Michael S. Dina and has published in prestigious journals such as Journal of Medicinal Chemistry, Organic Letters and Tetrahedron Letters.

In The Last Decade

Edward L. Conn

12 papers receiving 259 citations

Peers

Countries citing papers authored by Edward L. Conn

Since Specialization

Citations

This map shows the geographic impact of Edward L. Conn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward L. Conn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward L. Conn more than expected).

Fields of papers citing papers by Edward L. Conn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward L. Conn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward L. Conn. The network helps show where Edward L. Conn may publish in the future.

Co-authorship network of co-authors of Edward L. Conn

This figure shows the co-authorship network connecting the top 25 collaborators of Edward L. Conn. A scholar is included among the top collaborators of Edward L. Conn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward L. Conn. Edward L. Conn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptor 2023 ·Bioorganic & Medicinal Chemistry Letters ·Gary E. Aspnes, Scott W. Bagley, Steven B. Coffey, Edward L. Conn, John M. Curto, David J. Edmonds, Julien Genovino, David A. Griffith, (unknown), Wenhua Jiao, Chris Limberakis, Alan M. Mathiowetz, David W. Piotrowski, Colin R. Rose, Roger B. Ruggeri, Liuqing Wei	4
2	Identification of parallel medicinal chemistry protocols to expand branched amine design space 2022 ·Organic & Biomolecular Chemistry ·Edward L. Conn, Matthew A. Perry, (unknown), Guotao Wang, (unknown), Neal W. Sach, (unknown), (unknown), Yu Gao, Yan Xu, Daniel C. Schmitt	2
3	Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1) 2018 ·ACS Medicinal Chemistry Letters ·Kevin J. Filipski, M. F. Sammons, Samit K. Bhattacharya, Jane Panteleev, Janice A. Brown, Paula M. Loria, Markus Boehm, Aaron Smith, Andre Shavnya, Edward L. Conn, Kun Song, Yan Weng, Carie Facemire, Harald Jüppner, Valérie Clerin	24
4	Species Differences in the Oxidative Desulfurization of a Thiouracil-Based Irreversible Myeloperoxidase Inactivator by Flavin-Containing Monooxygenase Enzymes 2016 ·Drug Metabolism and Disposition ·Heather Eng, Raman Sharma, Angela Wolford, Li Di, Roger B. Ruggeri, Leonard Buckbinder, Edward L. Conn, Deepak Dalvie, Amit S. Kalgutkar	8
5	Expedient Synthesis of α-(2-Azaheteroaryl) Acetates via the Addition of Silyl Ketene Acetals to Azine-N-oxides 2014 ·Organic Letters ·Allyn T. Londregan, (unknown), Edward L. Conn, Kevin D. Hesp	43
6	1,4-Addition of an aryllithium reagent to diethyl ketomalonate. Scalable synthesis of ethyl 1-(hydroxymethyl)-1,3-dihydroisobenzofuran-1-carboxylate 2012 ·Tetrahedron Letters ·Benjamin N. Rocke, Edward L. Conn, Shane A. Eisenbeis, Roger B. Ruggeri	2
7	Insights into the Novel Hydrolytic Mechanism of a Diethyl 2-Phenyl-2-(2-arylacetoxy)methyl Malonate Ester-Based Microsomal Triglyceride Transfer Protein (MTP) Inhibitor 2012 ·Chemical Research in Toxicology ·Tim F. Ryder, Gregory S. Walker, Theunis C. Goosen, Roger B. Ruggeri, Edward L. Conn, Benjamin N. Rocke, Kimberly Lapham, Claire M. Steppan, David Hepworth, Amit S. Kalgutkar	5
8	Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Paul S. Humphries, John W. Benbow, Paul D. Bonin, (unknown), Shawn D. Doran, Richard K. Frisbie, David W. Piotrowski, (unknown), Bruce M. Bechle, Edward L. Conn, Kenneth J. DiRico, Robert M. Oliver, Walter C. Soeller, (unknown), Xiaojing Yang	47
9	Chemically-enabled synthesis of 1,2,3,4-tetrahydroisoquinolin-1-ones 2009 ·Tetrahedron Letters ·Paul S. Humphries, (unknown), Bruce M. Bechle, Edward L. Conn, Kenneth J. DiRico, Hui Yu, Robert M. Oliver, (unknown), Xiaojing Yang	7
10	A Novel Series of Non-Carboxylic Acid, Non-Hydantoin Inhibitors of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one and Congeners 2005 ·Journal of Medicinal Chemistry ·Banavara L. Mylari, (unknown), David A. Beebe, Edward L. Conn, James B. Coutcher, Michael S. Dina, Melissa O’Gorman, Michael C. Linhares, William H. Martin, Peter J. Oates, David A. Tess, (unknown), William J. Zembrowski	53
11	A Highly Selective, Non-Hydantoin, Non-Carboxylic Acid Inhibitor of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran- 2-sulfonyl)-2-H-pyridazin-3-one 2003 ·Journal of Medicinal Chemistry ·Banavara L. Mylari, (unknown), David A. Beebe, Edward L. Conn, James B. Coutcher, Michael S. Dina, Melissa O’Gorman, Michael C. Linhares, William H. Martin, Peter J. Oates, David A. Tess, (unknown), William J. Zembrowski	63
12	A Sorbitol Dehydrogenase Inhibitor of Exceptional in Vivo Potency with a Long Duration of Action: 1-(R)-{4-[4-(4,6-Dimethyl[1,3,5]triazin-2-yl)- 2R,6S-dimethylpiperazin-1-yl]pyrimidin-2- yl}ethanol 2002 ·Journal of Medicinal Chemistry ·Banavara L. Mylari, Peter J. Oates, William J. Zembrowski, David A. Beebe, Edward L. Conn, James B. Coutcher, Melissa O’Gorman, Michael C. Linhares, (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact